Mostrando 2 resultados de: 2
Clinical manifestations and evaluation of postmenopausal vulvovaginal atrophy
ReviewAbstract: Introduction: It is estimated that 50% of women will suffer a severe form of vulvovaginal atrophy (VPalabras claves:atrophic vaginitis, diagnosis, dyspareunia, genitourinary syndrome of menopause, MENOPAUSE, vulvovaginal atrophy, women’s sexual healthAutores:Cohen-Sacher B., Faustino R. Pérez-López, Fialho S.C.A.V., Phillips N., Stockdale C.K., Vieira–Baptista P.Fuentes:scopusManagement of postmenopausal vulvovaginal atrophy: recommendations of the International Society for the Study of Vulvovaginal Disease
ArticleAbstract: Objective: To develop a best practice document for the management of postmenopausal vulvovaginal atrPalabras claves:Androgens, Breast Cancer, estriol, estrogens, LÁSER, lubricants, ospemifene, prasterone, SERMs, vaginal moisturizers, vulvovaginal atrophyAutores:Cohen-Sacher B., Faustino R. Pérez-López, Fialho S.C.A.V., Phillips N., Stockdale C.K., Vieira–Baptista P.Fuentes:scopus